Related Experiment Video
Updated: Aug 21, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
DNA methylation and cancer
1Department of Medicine, Miami VA Medical Center, Miami, FL, USA.
Abstract:
DNA methylation is an important regulator of gene transcription, and its role in carcinogenesis has been a topic of considerable interest in the last few years. Alterations in DNA methylation are common in a variety of tumors as well as in development. Of all epigenetic modifications, hypermethylation, which represses transcription of the promoter regions of tumor suppressor genes leading to gene silencing, has been most extensively studied. However, global hypomethylation has also been recognized as a cause of oncogenesis. New information concerning the mechanism of methylation and its control has led to the discovery of many regulatory proteins and enzymes. The contribution of dietary folate and methylene terahydrofolate reductase polymorphisms to methylation patterns in normal and cancer tissues is under intense investigation. As methylation occurs early and can be detected in body fluids, it may be of potential use in early detection of tumors and for determining the prognosis. Because DNA methylation is reversible, drugs like 5'-azacytidine, decitabine, and histone deacetylase inhibitors are being used to treat a variety of tumors. Novel demethylating agents such as antisense DNA methyl transferase and small interference RNA are being developed, making the field of DNA methylation wider and more exciting.
Insights
DNA methylation, an epigenetic process, significantly impacts gene transcription and cancer development. Aberrant DNA methylation patterns, including hypermethylation and hypomethylation, are crucial in oncogenesis and offer potential for early tumor detection and therapeutic strategies.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- DNA methylation is a key epigenetic mechanism regulating gene transcription.
- Alterations in DNA methylation are frequently observed in various cancers and during development.
- Both promoter hypermethylation (silencing tumor suppressor genes) and global hypomethylation contribute to oncogenesis.
Purpose of the Study:
- To review the role of DNA methylation in carcinogenesis.
- To discuss the mechanisms and regulatory proteins involved in DNA methylation.
- To explore the potential of DNA methylation in cancer detection, prognosis, and therapy.
Main Methods:
- Literature review focusing on DNA methylation in cancer.
- Analysis of epigenetic modifications, including hypermethylation and hypomethylation.
- Investigation of regulatory proteins, enzymes, and dietary factors (e.g., folate) influencing methylation.
Main Results:
- DNA methylation alterations are common in tumors.
- Hypermethylation of tumor suppressor genes leads to silencing.
- Global hypomethylation can also drive oncogenesis.
- Dietary factors and genetic polymorphisms (e.g., MTHFR) impact methylation patterns.
Conclusions:
- DNA methylation is a critical factor in cancer development.
- Early detection and prognosis may be improved by analyzing methylation patterns in body fluids.
- Reversible nature of DNA methylation allows for therapeutic interventions using demethylating agents.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer Prevention
Some...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

